Promising drug for rare balance disorder enters final testing phase
NCT ID NCT07185347
First seen Nov 01, 2025 · Last updated Jun 15, 2026 · Updated 31 times
Summary
This study tests whether the drug fampridine can improve walking and daily function in people with a rare genetic balance disorder called SCA27B. About 70 adults with this condition will receive either fampridine or a placebo for 3 months. The goal is to see if the drug reduces movement problems, based on earlier small studies that showed promising results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINOCEREBELLAR ATAXIA 27B (SCA27B) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Genetics Department, CHU de Bordeaux
RECRUITINGBordeaux, France
Contact
-
Genetics Department, CHU de Rouen
NOT_YET_RECRUITINGRouen, France
Contact
-
Genetics Department, Pitié-Salpêtrière University Hospital
RECRUITINGParis, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Neurology Department, CHRU de Strasbourg
NOT_YET_RECRUITINGStrasbourg, France
Contact
-
Neurology Department, CHU d'Angers
NOT_YET_RECRUITINGAngers, France
Contact
-
Neurology Department, CHU de Toulouse
NOT_YET_RECRUITINGToulouse, France
Contact
-
Neurology Department, Gui De Chauliac Hospital
RECRUITINGMontpellier, France
Contact
-
Neurology Department, Hôpital Pierre Wertheimer Hospital
NOT_YET_RECRUITINGLyon, France
Contact
Contact
-
Neurology and Gentics Department, CHU de Dijon
RECRUITINGDijon, France
Contact
Conditions
Explore the condition pages connected to this study.